These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


210 related items for PubMed ID: 4405404

  • 1. [Immunosuppressive agents].
    Stüttgen G.
    Arch Dermatol Forsch; 1972; 244():406-9. PubMed ID: 4405404
    [No Abstract] [Full Text] [Related]

  • 2. [Auto-immune diseases and immunodepressive therapy. II. Current clinical indications].
    Delespesse G, Kennes B, Duchateau J.
    Acta Clin Belg; 1974; 29(6):413-23. PubMed ID: 4155218
    [No Abstract] [Full Text] [Related]

  • 3. Medical treatment of connective tissue disease.
    Ciavaglia SJ, Costello PB, Panara N.
    Ear Nose Throat J; 1987 Nov; 66(11):457-62. PubMed ID: 3443075
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The management of collagen diseases.
    Calin A.
    Ration Drug Ther; 1980 Jan; 14(1):1-5. PubMed ID: 7384531
    [No Abstract] [Full Text] [Related]

  • 6. [Dementia due to cerebral vasculitis].
    Kitagawa Y.
    Nihon Rinsho; 2004 Jan; 62 Suppl():435-40. PubMed ID: 15011401
    [No Abstract] [Full Text] [Related]

  • 7. The use of corticosteroid agents in connective tissue disorders.
    Barraclough D.
    Med J Aust; 1986 Apr 14; 144(8):427-32. PubMed ID: 2870416
    [No Abstract] [Full Text] [Related]

  • 8. Clinical use of immunosuppressive drugs: part I.
    Gerber NL, Steinberg AD.
    Drugs; 1976 Apr 14; 11(1):14-35. PubMed ID: 770131
    [Abstract] [Full Text] [Related]

  • 9. Practical use of immunosuppressive drugs in autoimmune rheumatic diseases.
    De Jesus A, Talal N.
    Crit Care Med; 1990 Feb 14; 18(2 Suppl):S132-7. PubMed ID: 2298028
    [Abstract] [Full Text] [Related]

  • 10. [Indications and limits of long-term therapy with immunosuppressive (and cytostatic) agents in various chronic skin diseases].
    Schulze P.
    Z Arztl Fortbild (Jena); 1977 Jun 15; 71(12):562-4. PubMed ID: 20701
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of autoimmune diseases].
    Moeschlin S.
    Schweiz Med Wochenschr; 1971 Oct 02; 101(39):1393-9. PubMed ID: 4401236
    [No Abstract] [Full Text] [Related]

  • 12. [Hyperergic collagenoses. Clinical aspects, differential diagnosis and therapy (author's transl)].
    Alexander M, Kampf D.
    MMW Munch Med Wochenschr; 1977 Oct 21; 119(42):1357-64. PubMed ID: 22036
    [Abstract] [Full Text] [Related]

  • 13. [Immunodepressive agents in neurology].
    Sabouraud O.
    Rev Prat; 1986 Jan 21; 36(5):229-36. PubMed ID: 2870559
    [No Abstract] [Full Text] [Related]

  • 14. [Immunosuppressive therapy of collagenoses].
    Miescher PA.
    Verh Dtsch Ges Inn Med; 1972 Jan 21; 78():774-7. PubMed ID: 4146711
    [No Abstract] [Full Text] [Related]

  • 15. Therapy of neurological disorders in systemic vasculitis.
    Gold R, Fontana A, Zierz S.
    Semin Neurol; 2003 Jun 21; 23(2):207-14. PubMed ID: 12894386
    [Abstract] [Full Text] [Related]

  • 16. Ocular manifestations of rheumatic disorders. Natural and iatrogenic.
    Henkind P, Gold DH.
    Rheumatology; 1973 Jun 21; 4(0):13-59. PubMed ID: 4151989
    [No Abstract] [Full Text] [Related]

  • 17. [Pathology of angiitis (author's transl)].
    Hosoda Y.
    Ryumachi; 1980 Feb 21; 20(1):42-56. PubMed ID: 6104362
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The treatment of collagen diseases].
    Calin A.
    Internist (Berl); 1980 Nov 21; 21(11):697-701. PubMed ID: 7005164
    [No Abstract] [Full Text] [Related]

  • 20. [Systemic vasculitis: study of 27 cases in Senegal].
    Ndongo S, Diallo S, Tiendrebeogo J, Diop IB, Tall A, Pouye A, Ka MM, Diop TM.
    Med Trop (Mars); 2010 Jun 21; 70(3):264-6. PubMed ID: 20734595
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.